OMAHA, Neb., Nov. 6 /PRNewswire-FirstCall/ -- Transgenomic (OTC
Bulletin Board: TBIO) today announced that Craig Tuttle, President and CEO
of Transgenomic, will present at the Rodman & Renshaw 10th Annual
Healthcare Conference to be held November 10-12, 2008 at the New York
Palace Hotel in New York City. Mr. Tuttle and Debra Schneider, Chief
Financial Officer, will be available to respond to questions during the
Event: Rodman & Renshaw 10th Annual Healthcare Conference
Date: Wednesday, November 12, 2008
Time: 2:00 p.m. ET
Place: New York Palace Hotel, Adams (4th Floor)
The presentation will be webcast live and can be accessed through the provided link:
Transgenomic (OTC-Bulletin Board: TBIO.OB) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis. The Company provides products and services in the fields of pharmacogenomics and pharmacogenetics.
Product offerings include the WAVE(R) DHPLC Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1600 systems have been shipped to customers in more than 30 countries. The SURVEYOR(R) Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for the detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods.
Service offerings include the Transgenomic Clinical Reference
Laboratory, which provides reference laboratory services specializing in
molecular diagnostics including Mitochondrial Disorders, Oncology and
Hematology, Molecular Patholo
Copyright©2008 PR Newswire.
All rights reserved